RE: RE: RE: RE: Setting up well- AEZyour business case comment matches my expectations as well.
At the AGM, there was an expectation that interest might come from niche players. I doubt that at this time; it will be the big boys. The cancer efforts have always been a under-the-radar kicker that may attract a surprisingly good buyout, imo.
Aporpos the bph palcebo effect, I know it will be there, based on other studies. However, I think that the 90 day follow up will reduce it somewhat, again imo.
Anyways, with results 2 - 3 weeks away, I am not surprised to see the sp surging. Months ago I predicted in teh 70 prior to the release of 2b. I may have been conservative.
Nice to see another interested and informed poster.